↓ Skip to main content

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

Overview of attention for article published in Annals of Surgical Oncology, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
37 Mendeley
Title
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology
Published in
Annals of Surgical Oncology, December 2014
DOI 10.1245/s10434-014-4247-8
Pubmed ID
Authors

Cristina R. Ferrone, David T. Ting, Mohammed Shahid, Ioannis T. Konstantinidis, Francesco Sabbatino, Lipika Goyal, Travis Rice-Stitt, Ayesha Mubeen, Kshitij Arora, Nabeel Bardeesey, John Miura, T. Clark Gamblin, Andrew X. Zhu, Darrell Borger, Keith D. Lillemoe, Miguel N. Rivera, Vikram Deshpande

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 30%
Student > Postgraduate 4 11%
Student > Doctoral Student 3 8%
Other 3 8%
Student > Ph. D. Student 3 8%
Other 4 11%
Unknown 9 24%
Readers by discipline Count As %
Medicine and Dentistry 14 38%
Biochemistry, Genetics and Molecular Biology 6 16%
Social Sciences 2 5%
Agricultural and Biological Sciences 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 5%
Unknown 11 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2017.
All research outputs
#6,410,071
of 22,775,504 outputs
Outputs from Annals of Surgical Oncology
#2,168
of 6,452 outputs
Outputs of similar age
#87,791
of 353,309 outputs
Outputs of similar age from Annals of Surgical Oncology
#24
of 97 outputs
Altmetric has tracked 22,775,504 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 6,452 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,309 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.